MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
VINP
Vinci Compass Investments Ltd.
There isn't enough reported data to score VINP yet.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
VINP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| N/A | |
| N/A |
VINP's revenue is currently healthy, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like VINP.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
VINP PE Valuation
VINP has no meaningful PE right now: it lost money over the past year.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over VINP on the outlook, with more favorable earnings and revenue expectations.
VINP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect VINP's earnings and profitability to decline, with its revenue holding steady.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the stronger earnings trend. Trailing diluted EPS is up 29% for MS versus VINP down 49%.
VINP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | $0.38 | -49% |
| Q3 2024 | $0.59 | -18% |
| Q2 2024 | $0.55 | -35% |
| Q1 2024 | $0.75 | +5.6% |
| Q4 2023 | $0.74 | +4.2% |
| Q3 2023 | $0.72 | +2.9% |
| Q2 2023 | $0.85 | +35% |
| Q1 2023 | $0.71 | +9.2% |
VINP's earnings per share have fallen from their peak: $0.38 over the past year, against $0.85 in mid-2023.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over VINP on profitability, with a higher operating margin.
VINP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $50.1M | +2.1% |
| Q1 2026 | $49.2M | +17% |
| Q4 2025 | $131.8M | +183% |
| Q3 2025 | $63.5M | +188% |
| Q2 2025 | $49M | +86% |
| Q1 2025 | $42M | +115% |
| Q4 2024 | $46.6M | +60% |
| Q3 2024 | $22.1M | +4.6% |
VINP has the edge over MS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 28% | +6.1 points |
| Q1 2026 | 32% | +3.4 points |
| Q4 2025 | 26% | N/A |
| Q3 2025 | -49% | -67 points |
| Q2 2025 | 21% | -17 points |
| Q1 2025 | 29% | -3.7 points |
| Q4 2024 | 18% | -15 points |
| Q3 2024 | 38% | -2.1 points |
VINP's operating margin was 28% last quarter, up 6.1 points from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
VINP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $10.9M | +6.6% |
| Q1 2026 | -$5M | -449% |
| Q4 2025 | $10.7M | +$11.5M |
| Q3 2025 | $18.3M | +$31.4M |
| Q2 2025 | $10.2M | -63% |
| Q1 2025 | $1.4M | -93% |
| Q4 2024 | -$802.1K | -108% |
| Q3 2024 | -$13.1M | -234% |
VINP has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over VINP on shareholder dilution, with a more favorable share count trend.
VINP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.4% | +2.9M shares |
| 1 year | +6.7% | +4.3M shares |
| 3 years | +20% | +11.6M shares |
| 5 years | +32% | +16.7M shares |
| Available history | +23% | +12.8M shares |
VINP has 68M diluted shares, up 6.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $387,401 |
| Q3 2025 | $333,889 |
| Q2 2025 | $1.6M |
| Q1 2025 | $7.2M |
| Q4 2024 | $6.5M |
| Q3 2024 | $4M |
VINP spent $721,290 buying back its own shares over the past year, down 96% from the year before.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
VINP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q4 2024 | 3.3x | Elevated |
| Q3 2024 | 2.4x | Moderate |
| Q2 2024 | 2.8x | Moderate |
| Q1 2024 | 2.2x | Moderate |
| Q4 2023 | 2.5x | Moderate |
VINP has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
VINP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.1 | Neutral |
| Stochastic | 8.0 | Oversold |
VINP's weekly RSI is 41 (neutral) and its Stochastic is 8 (oversold).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
VINP PE vs Financial Services Sector
| Metric | VINP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
VINP has no meaningful PE right now: it lost money over the past year.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over VINP on trend strength, trading above more of its moving averages.
VINP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.87 | 11% below |
| 20 week MA | $9.74 | 9.5% below |
| 50 week MA | $10.7 | 18% below |
| 100 week MA | $10.5 | 16% below |
| 200 week MA | $10.3 | 14% below |
VINP is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over VINP on returns for 2026, with the stronger performance.
VINP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $17.1 | $11.2 | -34% |
| 2022 | $11.2 | $8.37 | -25% |
| 2023 | $8.37 | $11.0 | +31% |
| 2024 | $11.0 | $10.0 | -8.5% |
| 2025 | $10.0 | $13.1 | +31% |
| 2026 YTD | $13.1 | $8.81 | -33% |
VINP has finished lower in three of the last five years. It's down 33% so far in 2026.